Can gene editing truly support smallholder farmers and help Indonesia achieve food sovereignty, or will it simply revive the old controversies surrounding GMO crops?

Early results from a study of newborn screening methods show that DNA analysis picks up many more preventable or treatable serious health conditions than standard newborn screening and is favored by ...

Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in ...

The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...

Metagenomi announces successful integration of large genes in human cells using a novel, compact CAST system for potential therapeutic applications. Metagenomi, Inc., a precision genetic medicines ...

India's first gene-edited sheep recently turned a year old and researchers who developed it say it's doing well. Born on 16 ...

Malaria remains one of the world’s deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five. The ...

Genetic sequencing has gone through several advances. A major breakthrough came when scientists began breaking the billions of letters that compose DNA up into relatively small bits of a few hundred ...

On a special episode (first released on June 20, 2024) of The Excerpt podcast: With the advent of CRISPR as a gene editing technology, there are new opportunities to develop breakthrough treatments ...

The UWA Tech & Policy Lab receives funding from nationally competitive research grants and philanthropic partners. The present research was supported by GA308883: Effective Ethical Frameworks for the ...

Canada is ready for the next genetic revolution. Farmers like me applaud the Canadian Food Inspection Agency (CFIA) for letting sound science guide agricultural policy—and clearing up the ...

A team of researchers report findings from a Phase I/II gene therapy clinical trial for patients with Leber congenital amaurosis, which found that the gene therapy could significantly restore eyesight ...